The neural histaminergic system modulates cognitive performance in various animal models. However, little is known about the effects of the H4 histaminergic receptor in the central nervous system. The purpose of this study was to investigate the effect of histaminergic H4 agonist VUF-8430 microinjection into the cerebellar vermis on the consolidation of emotional memory in mice subjected to the elevated plus maze (EPM) and inhibitory avoidance task (IAT). All experiments were performed on two consecutive days: exposure (T1 and D1) and 24 h after, which we called re-exposure (T2 and D2). The animals received saline (SAL) or VUF (0.15 nmol; 0.49 nmol; 1.48 nmol/0.1 μl) administered post-exposure. Experiment 1 was conducted in the EPM, and the animals were free to explore the maze for 5 min. In T1, immediately after exposure, the pharmacological treatment was given; in T2, there was only re-exposure to the EPM. Experiment 2 involved the IAT, and the pharmacological treatment was provided post-D1; in D2, the animals were only re-exposed to the IAT. In Experiment 1, increased open arm exploration (% open arm entries and% open arms time) for 0.49 and 1.48 nmol of VUF were recorded in T2 compared to T1. In Experiment 2, a significant decrease in consolidation latency was recorded for the group that received 1.48 nmol of VUF compared to the SAL group in D2. These results indicate that a 1.48 nmol VUF microinjection into the cerebellar vermis impaired performance in both models, even though one model was anxiety-mediated (EPM) and the other was fear-mediated (IAT).
Introduction
The main stages of memory formation include three phases that comprise acquisition, consolidation and retrieval processes (Kandel et al., 2013) . The process of consolidation is vulnerable to pharmacological and/or behavioral interference, and it is required for long-term memory formation (Glaser et al., 2010) . In addition, memory consolidation may be modulated by characteristic endogenous neuroendocrine factors related to levels of stress and anxiety (Mcgaugh, 2006; Roozendaal et al., 2009 ). Furthermore, there are studies indicating a functional interactions network among several brain regions, modulating the memory processes (Fudge et al., 2012; Steinmetz et al., 2017) .
Behavioral evidence in animals and humans suggest a role of the cerebellum in the regulation of emotional states related to cognitive and motor behaviors (Adamaszek et al., 2017) . Storage of motor memories has been found within the cerebellum and its associated brainstem circuitry, indicating that this structure highlights the mechanisms involved in motor learning (Longley and Yeo, 2014) . In relation to emotions, studies have indicated the involvement of the cerebellum in the consolidation of aversive and emotional memory in rodents (Sacchetti et al., 2002; Silva-Marques et al., 2016) . These results contribute to understanding the cerebellum participates in regulation of emotional learning and memory and not only in the regulation of motor control.
It is known that the histaminergic system actively participates in cerebellum-mediated motor balance, coordination and emotional functions (Li et al., 2014; Gianlorenço et al., 2015) . At least four types of receptors mediate the actions of the biological effects of histamine, including H1, H2, H3 and H4 receptors (Strakhova et al., 2009; Haas and Panula, 2003) . Previous studies conducted in our laboratory investigated the modulation of emotional memory by histamine receptors present in the cerebellum using the elevated plus maze (EPM) and an inhibitory avoidance task (IAT). In EPM model, histamine infusions in the cerebellar vermis were shown to impair consolidation of emotional memory in mice via H1 receptors (Gianlorenço et al., 2012) and via H3 receptors (Costa Neto et al., 2013) . In contrast, histaminergic modulation of vermis activity via H2 receptors enhances mediate fear memory consolidation in mice (Gianlorenço et al., 2015) .
The participation of H1-H3 receptors in the modulation of emotional memory consolidation is well discussed in the literature; however, there is no study showing the role of the H4 histaminergic receptors in this process, because it was recently discovered that H4 receptors are expressed in the central nervous system (CNS) (Strakhova et al., 2009; Connelly et al., 2009) ; previously, its role was only attributed to the peripheral nervous system and was thought to be involved in inflammatory responses. A study by Galeotti et al. (2013) demonstrated that intracerebroventricular microinjections of VUF-8430, an H4 receptor agonist, reversed emotional memory deficits induced by scopolamine in mice submitted to an IAT and showed an anxiolytic-like effect in the light-dark box test. However, the microinjection alone did not show effects on emotional memory. According to Lim et al. (2009) , this drug demonstrated high affinity for the H4 receptors, although it has an affinity for the H3 receptors and can serve as a pharmacological tool for future studies to validate the H4 receptor as a new drug target in the CNS.
Considering that the histaminergic system in the cerebellar vermis has been shown to have effects on emotional memory through different receptors, this study may help to clarify the role of the H4 receptor in the cerebellar vermis as well as its relationship to learning processes and the consolidation of emotional memory in mice. Therefore, the aim of the present study was to investigate the effects of VUF-8430 microinjection into the cerebellar vermis on two models, one anxiety-mediated and the other fear-mediated, during memory consolidation.
Experimental procedure

Animals
The experimental subjects were 86 adult male Swiss mice (Federal University of Sao Carlos, SP, Brazil), aged from 5 to 7 weeks and weighing 25-40 g at testing. The mice were housed in groups of 5 per cage (28 × 18 × 11 cm) and maintained under a 12-h light cycle (lights on at 7 a.m.) in a controlled environment at a temperature of 23 ± 1°C and a relative humidity of 50 ± 5%. Food and drinking water were provided ad libitum, except during the brief testing periods. All mice were naïve to behavioral tests at the beginning of the study. The experimental sessions were conducted during the light period of the cycle (9 a.m.-2 p.m.). All of the tests were performed under illumination of nearly 100 lx.
All procedures were approved by the Ethics Committee on Animal Experimentation of the Federal University of Sao Carlos (Process #8336250515) and complied with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Drug
VUF-8430 (Sigma Chemical Co., St. Louis, MO, USA), an H4 receptor agonist, was dissolved in sterile 0.9% saline solution (SAL). The VUF solution was microinjected at doses of 0.15 nmol, 0.49 nmol and 1.48 nmol in a volume of 0.1 μl. The doses were selected based on a previous study conducted by Galeotti et al. (2013) . The solutions were stored in coded tubes.
Surgery and microinjection
Mice were intraperitoneally anesthetized using a solution of ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg) and then were treated with local anesthesia in scalp (3% lidocaine with norepinephrine 1:50,000) and placed in a Stoelting stereotaxic instrument. A single 7-mm stainless steel guide cannula (25 gauge) was implanted in the cerebellar vermis according to the following coordinates from the mouse brain atlas of Franklin and Paxinos (2001) : 6.5 mm posterior to the Bregma; 0 mm lateral to the midline; and 2.0 mm ventral to the skull surface. The guide cannula was fixed to the skull using dental acrylic and jeweler's screws. A dummy cannula (33-gauge stainless steel wire) was inserted into the guide cannula to reduce the incidence of occlusion. Postoperative analgesia was provided for 3 days by adding acetaminophen (200 mg/ml) to the drinking water at a ratio of 0.2 ml acetaminophen to 250 ml water for a final concentration of 0.16 mg/ ml.
After four days of the animal's recovery from the surgery, saline and drug solutions were infused into the cerebellar vermis using a microinjection unit (33-gauge cannula) that extended 1 mm beyond the tip of the guide cannula. The microinjection unit was attached to a 5-μl Hamilton microsyringe via polyethylene tubing (PE-10) and the administration was controlled by an infusion pump (BI2000, Insight Equipamentos Cientificos Ltda.) programmed to deliver a volume of 0.1 μl over a period of 60 s. The microinjection procedure consisted of gently restraining the animal, removing the dummy cannula, inserting the injection unit, infusing the solution and keeping the injection unit in situ for an additional 60 s. Successful infusion was confirmed by monitoring the movement of a small air bubble in the PE-10 tubing.
2.4. Apparatus, experimental procedure and behavioral analysis 2.4.1. Experiment 1. Elevated plus maze EPM testing was similar to that developed by Lister (1987) . The test is widely employed to score anxiety levels in rodents (Carobrez and Bertoglio, 2005; Galvis-Alonso et al., 2010) . The acrylic maze was elevated to a height of 38.5 cm and consisted of four arms, two of which were open (30 × 6 × 0.6 cm) and two of which were enclosed (30 × 6 × 15.5 cm). The arms extended from a common central platform (6 × 6 cm).
The tests were performed on two consecutive days (exposure T1 and re-exposure T2). The experiment began by transferring the mice to the test room, where they were allowed to rest for 1 h, and then the animals were placed individually in the center of the plus-maze facing an open arm and were allowed to explore the maze for 5 min. In T1, immediately after exposure to the EPM, the animals received the following microinjections: SAL or VUF (0.15 nmol, 0.49 nmol or 1.48 nmol/ 0.1 μl). Twenty-four hours later (T2), the mice were re-exposed to the EPM under the same experimental conditions as T1, except they did not receive a microinjection. Between subjects, the maze was thoroughly cleaned with 5% ethanol and a dry cloth to avoid possible bias due to odors and/or residues left by mice that were tested earlier. All sessions were video-recorded using a digital camera positioned above the maze and linked to a computer in an adjacent room. The images were analyzed by a trained observer using the XPLOT-RAT ethological analysis software developed at the Laboratory of Exploratory Behavior, USP/ Ribeirao Preto (Becerra-Garcia et al., 2005) .
Behavioral parameters were defined according to previous studies (Rodgers and Johnson, 1995; Lister, 1987) and included the following: frequencies of open-and enclosed-arm entries (OAE and EAE) (arm entry = all four paws within an arm), total arm entries (TE), total time spent in open arms (OAT), total time spent in enclosed arms (EAT), and total time spent in the central area (CT). These data were used to calculate the percentages of OAE [% OAE; (OAE/TE) × 100] and OAT [% OAT; (OAT/300) × 100]. An increase in open-arm avoidance with repeated maze exposure has been observed to be a measure of learning and memory evaluated by T1/T2 (test/retest) protocols (Canto-DeSouza et al., 2015; Serafim et al., 2016) . Enclosed arm entries (EAE) are considered a locomotor activity measurement in the EPM.
Experiment 2. Inhibitory avoidance task
IAT was conducted through a two-trial learning step-through situation (Fine et al., 1985; Page et al., 1991 ). An inhibitory avoidance apparatus consisted of an acrylic box (48 × 27 × 30 cm) containing two compartments of the same size, including one bright (crystal colored, under illumination 400 lx, 24 × 13.5 × 15 cm) and one dark (with black acrylic, 24 × 13.5 × 15 cm), that were separated by a guillotine type door (7 × 7 cm) in the middle of a divider wall. The floor was made of stainless-steel rods (2.5 mm in diameter) spaced 1 cm apart that delivered electric shocks at an intensity of 0.5 mA for 3 s. The box was connected to a computer with software (Insight Equipamentos Cientificos Ltd., Brazil) that triggered the functions of the apparatus, and a camera was placed above the box to record the sessions (Surveillance System GV-600; GeoVision, Inc.; Neihu District, Taipei, Taiwan).
The tests were performed on two consecutive days (exposure D1 and re-exposure D2). In D1, mice were placed in the apparatus after 1 h of habituation in the experimental room. Each animal was gently placed in the light compartment for 5 s, and then, the guillotine door was lifted. The latency of the animal crossing to the dark (shock) compartment was timed. Animals that waited for more than 100 s to cross to the other side were excluded. Once the animal crossed to the next compartment with all four paws, the door was closed and the mouse was moved to its home cage. In D1, the acquisition trial was followed by the guillotine door closing and a foot shock (0.5 mA, 3 s) delivered immediately after the animal had entered the dark compartment. After 20 s, the mouse was removed from the apparatus and placed temporarily in its home cage. Two minutes later, the animal was retested in the same fashion, and if the mouse did not enter the dark compartment during the 120 s period, a successful acquisition of inhibitory avoidance response was recorded. Otherwise, when the mouse entered the dark compartment a second time, the door was closed and the mouse received the same shock as before. After retesting, if the animal successfully achieved inhibitory avoidance, it was removed from the apparatus and received one of the following microinjections via the guide cannula: saline (SAL) or VUF (0.15, 0.49 or 1.48 nmol). If inhibitory avoidance was not achieved, the animal was excluded.
Twenty-four hours after training, a retention test was performed to determine memory consolidation (D2). Each animal was placed in the light compartment for 5 s, the door was opened, and the latency for entering the dark compartment was measured. The test session ended when the animal entered the dark compartment or remained in the light compartment for 300 s.
The apparatus was cleaned with wet cotton and 5% alcohol between the tests. The step-through latencies for entries into the dark compartment during D1 and D2 were manually measured by the experimenter using a stopwatch. The increase or decrease in latencies at D2 compared to D1 can be considered an improvement or impairment of memory consolidation, respectively.
Histology
At the end of the experiments, each animal received a 0.1-μl infusion of a 1% methylene blue solution to the cerebellar vermis using the procedure described above. The animals then received an anesthetic overdose, and their brains were removed and placed in formaldehyde solution (10%). Later, the brain tissues were coronally sectioned using a cryostat microtome 300 (ANCAP, Brazil). The injection sites were microscopically (Olympus B202) verified. Data from the animals with injection sites outside the vermis were excluded from the analysis.
The histological examinations confirmed that the cannula placements in the cerebellar vermis were accurate in 86 mice and that the sample sizes of the different experiments cohorts were as follows: Experiment 1: SAL (n = 10), VUF 0.15 nmol (n = 10), VUF 0.49 nmol (n = 10) and VUF 1.48 nmol (n = 10); Experiment 2: SAL (n = 10), VUF 0.15 nmol (n = 12), VUF 0.49 nmol (n = 12) and VUF 1.48 nmol (n = 12). These individuals were used to investigate the effects of intravermis microinjection of VUF-8430 on emotional behaviors. Microinjection tips were positioned in the vermis and methylene blue was within the cerebellar vermis (Fig. 1) . Therefore, the present results can be interpreted as chemical stimulation of the vermis.
Statistics
All data passed the tests of normality and variability, and all of the results were submitted to Levene's tests for homogeneity of variance. The data were analyzed using one-way ANOVA. Differences indicated by significant F values were further verified by post hoc Duncan's multiple range tests. In all cases, p < 0.05 was considered to be significant.
Results
3.1. Experiment 1: Intra-vermis microinjection of VUF-8430 at a dose of 0.49 nmol and 1.48 nmol impairs performance in the EPM Forty animals with histologically verified cannula placements were used in the first experiment. Fig. 2 AB and Table 1 show the treatment effects of the intra-vermis microinjections of VUF-8430 (0.15; 0.49; and 1.48 nmol) on the EPM behavioral measures. One-way ANOVA showed no significant difference between the groups in Trial 1 (T1) for all the measures analyzed. Therefore, the data were pooled because the animals had received no pharmacological treatment at that point.
ANOVA showed differences in% OAE between sessions [F(3,36) = 49.00, p < 0.001]. The post hoc analysis indicated that there was a reduction in the% OAE for groups that were microinjected with SAL and 0.15 nmol VUF in T2 in comparison to T1. Additionally, there was an increase in% OAE for VUF-treated groups at a dose of 0.49 and 1.48 nmol compared to the SAL group ( Fig. 2A) . In% OAT, there was a statistically significant trial effect [F(3,36) = 43.71, p < 0.001]. Duncan test indicated that there was a decrease in% OAT for an animal microinjected with SAL and VUF 0.49 nmol groups in T2 in comparison to T1. Moreover, the VUF-treated groups at doses of 0.49 and 1.48 had increased% OAT in relation to the SAL group (Fig. 2B) . Table 1 shows the results for all other behaviors. ANOVA did not indicate differences in EAE [F(3,36 3.2. Experiment 2: Intra-vermis microinjection of VUF at a dose of 1.48 nmol impairs performance in the IAT Forty-six animals with histologically verified cannula placements were used in the second experiment. Fig. 2 shows the results of comparisons between latencies recorded during D1 and D2 in the experimental groups that underwent an inhibitory avoidance task. One-way ANOVA showed no significant difference between the groups in Trial 1 (D1) for all the measures analyzed. Therefore, the data were pooled because the animals had received no pharmacological treatment at that point.
ANOVA testing indicated a difference between the sessions [F(3,42) = 6.02, p < 0.0002] and Duncan's test revealed a significant increase in the retention latency compared to that recorded in D1 for animals that received SAL and VUF-treated groups at doses of 0.15 nmol and 0.49 nmol. Additionally, there was a significant difference between groups in D2, and post hoc test indicated a decreased retention latency for the VUF-treated group at a dose of 1.48 nmol compared to the control group that received SAL (p < 0.0002) (Fig. 3) .
Discussion
The results obtained in Experiment 1 showed that microinjection of the H4 histaminergic receptor agonist VUF-8430 at doses of 0.49 and 1.48 nmol impaired memory consolidation, and this deficit was characterized by increased exploratory activity of animals in the open arms (% OAE and% OAT) observed in the 0.49 and 1.48 nmol VUF-treated groups in relation to the SAL group during re-exposure to the elevated plus maze (EPM). Additionally, there was an increase in the% OAT for these groups in T2 in relation to T1. The drug used at different dosages seems to induce no changes in locomotor activity, which was demonstrated by the enclosed arm entries (EAE) in the EPM.
The EPM was designed to evaluate anxiety (Lister, 1990) ; however, this model has also been proposed to assess emotional memory (Carobrez and Bertoglio, 2005) , which can be inferred by reductions in the exploration of the open arms during re-exposure (Galvis-Alonso et al., 2010; Daher and Mattioli, 2015) . The results of this study demonstrated that histamine via the H4 receptors impaired the consolidation of emotional memory in mice subjected to the EPM, which suggested there was an inhibitory role for this H4 histaminergic agonist at doses of 0.49 and 1.48 nmol of VUF microinjected into the cerebellar vermis of animals submitted to this model.
In addition to the EPM, a model designed to evaluate anxiety, we investigated the emotional behavioral response of the animals using the inhibitory avoidance task (IAT), which is an effective experimental paradigm that evaluates memory and involves fear-like behaviors (Nonankan et al., 2013) . In Experiment 2, when VUF-8430 (1.48 nmol) was microinjected post-D1 into the cerebellar vermis, there was a deficit in the consolidation of emotional memory, as noted in the decreased latencies in the 1.48 nmol VUF group compared to the control group SAL on the second day of testing (D2). Therefore, we inferred there was an amnestic effect of this drug at this dose. The other groups were treated with the VUF (0.15 nmol and 0.49 nmol), and the SAL group showed a response related to fear conditioning due to increased latencies in D2 compared to D1.
Our results showed that intra-vermis administration of 1.48 nmol of VUF did impair the consolidation of aversive information in mice submitted to the IAT. In another study, Galeotti et al. (2013) showed that VUF-8430 microinjected intracerebroventricularly in mice was able to reverse deficits in emotional memory induced by scopolamine in the IAT, but when the drug was microinjected alone, there was no effect on emotional memory in this model. These discrepancies concerning the modulation exerted by H4 receptors may be related to emotional arousal that is considered as a key endogenous modulator, and this condition may interact with mnemonic active agents provided by exogenous factors, such as drugs used at different doses (Mcgaugh, 1989) , injection sites, age and species of animal used to evaluate emotional memory. We cannot exclude that the impairment in emotional memory consolidation observed in the two tests might be secondary to an anxiolytic and/or panicolytic effects induced by the drug treatment, but our results showed that VUF-8430 microinjected post-trial 1 in mice impairs performance in anxiety-and fear-mediated models.
Histaminergic projections to the cerebellar vermis can be implicated in the modulation of emotional memory formation independent of its role in motor or sensory processes (Sacchetti et al., 2007; Sacchetti et al., 2009) . Recent results from our laboratory have traced the actions of histamine to H1-H3 receptors mechanisms in the cerebellar vermis using the EPM and IAT models. A study by Gianlorenço et al. (2013) showed that the participation of the cerebellar histaminergic system in the consolidation of emotional memory was dependent on a component of anxiety or fear, which indicated there are possible differences among models related to these components. High levels of histamine in the cerebellar vermis produced different results in models that assessed different functions, such as an anxiety component (Gianlorenço et al., 2011) or a fear component (Gianlorenço et al., 2015) . In the present study, an impairment of emotional memory consolidation was mediated by H4 receptors in both models (anxiety-and fear-mediated stimuli). Steimer (2002) suggested that anxiety and fear act as a signal of motivational conflict, i.e., threat or danger and trigger appropriate adaptive responses, likely showing some overlap in the underlying brain and behavioral mechanisms. Therefore, these findings indicate that histaminergic receptors in the cerebellar vermis use anxiety and fear models to implicate neural network circuits involved in different functions related to emotion.
Taken together, the results of experiments 1 and 2 helped to explain the effects produced by VUF-8430 in different experimental paradigms that were used to assess aversive memory. The two experimental models used in this study allowed for the evaluation of aversive memory related to different behavioral paradigms. While the EPM, which is a model related to anxiety, is based on exposure to potentially threatening areas on the first day of testing, the IAT is based on conditioned avoidance by a real danger related to the expression of fear. In this study, the highest dose (1.48 nmol) led to an amnestic effect in these two models even if the proposed tasks had different emotional natures.
While VUF-8430 also has an affinity to the H3 receptors as an agonist, we believe that the effect was, at least in part, due to the H4 receptors. We achieved this conclusion based on the comparison of different results obtained from previous studies involving the H3 receptors. Costa Neto et al. (2013) showed that an H3 antagonist thioperamide (THIO) microinjected into the cerebellar vermis impaired emotional memory consolidation in mice re-exposed to the EPM. A study by Charliera et al. (2013) indicated that post-training systemic administration of the same H3 antagonist facilitated memory consolidation in the IAT and Bernaerts et al. (2004) showed that THIO exerted a dose-dependent facilitative effect on memory consolidation on a step-through inhibitory avoidance apparatus. In the present study, an H4 agonist at the highest dose microinjected into the cerebellar vermis impaired memory consolidation in both models, the EPM and the IAT, therefore being different from H3 results, indicating a putative H4 effect.
Therefore, we suggest that the histaminergic neural system, via H4 receptors present in the cerebellar vermis, in mice could induce a deficit in the expression of emotional memory related to anxiety and fear in addition to impairing the consolidation phase when VUF-8430 was applied at a dose of 1.48 nmol.
Conclusion
These results indicate that VUF-8430 (1.48 nmol) microinjection into the cerebellar vermis induced an inhibitory effect on anxiety and/ or memory consolidation in the EPM and IAT models. Considering the different results involving H3 receptors in memory modulation, including previous studies from our laboratory, we believe that the results Groups: SAL (n = 10), VUF 0.15 nmol (n = 10), VUF 0.49 nmol (n = 10) and VUF 1.48 nmol (n = 10). *p < 0.05 for T2 compared to T1; #p < 0.05 for difference related to saline group in T2 (ANOVA followed by Duncan's post-hoc test).
Table 1
Effects of an intra-vermis infusion of SAL or VUF-8430 (0.15; 0.49; 1.48 nmol) post-T1 on behavioral measures of mice that were re-exposed to EPM testing. Data are reported as mean ± SEM. TE = total entries; EAE = enclosed arm entries; OAE = open arm entries; OAT = time spent in open arms; EAT = time spent in enclosed arms; CT = time spent in the central area. *p < 0.05 for T2 compared to T1; #p < 0.05 for difference related to saline group in T2 (ANOVA followed by Duncan's post-hoc test). of the present study may be attributed to the H4 receptors. This was the first study to investigate the actions of this histaminergic agonist in the cerebellar vermis, so there is a need for further studies to determine the role of H4 receptors in the central nervous system.
